Next Article in Journal
Investigation of Sex Differences in the Microglial Response to Binge Ethanol and Exercise
Next Article in Special Issue
Role of Immunological Memory Cells as a Therapeutic Target in Multiple Sclerosis
Previous Article in Journal
Immunotherapy for Pediatric Brain Tumors
Previous Article in Special Issue
Melanocortins, Melanocortin Receptors and Multiple Sclerosis
Article Menu

Export Article

Open AccessReview
Brain Sci. 2017, 7(10), 138; doi:10.3390/brainsci7100138

Pattern Recognition of the Multiple Sclerosis Syndrome

Department of Neurological Sciences, University of Nebraska Medical Center College of Medicine, Omaha, NE 68198-8440, USA
University of Nebraska Medical Center College of Nursing, Omaha, NE 68198-5330, USA
Author to whom correspondence should be addressed.
Received: 29 August 2017 / Revised: 29 September 2017 / Accepted: 17 October 2017 / Published: 24 October 2017
(This article belongs to the Special Issue Pathophysiology and Imaging Diagnosis of Demyelinating Disorders)
View Full-Text   |   Download PDF [4140 KB, uploaded 25 October 2017]   |  


During recent decades, the autoimmune disease neuromyelitis optica spectrum disorder (NMOSD), once broadly classified under the umbrella of multiple sclerosis (MS), has been extended to include autoimmune inflammatory conditions of the central nervous system (CNS), which are now diagnosable with serum serological tests. These antibody-mediated inflammatory diseases of the CNS share a clinical presentation to MS. A number of practical learning points emerge in this review, which is geared toward the pattern recognition of optic neuritis, transverse myelitis, brainstem/cerebellar and hemispheric tumefactive demyelinating lesion (TDL)-associated MS, aquaporin-4-antibody and myelin oligodendrocyte glycoprotein (MOG)-antibody NMOSD, overlap syndrome, and some yet-to-be-defined/classified demyelinating disease, all unspecifically labeled under MS syndrome. The goal of this review is to increase clinicians’ awareness of the clinical nuances of the autoimmune conditions for MS and NMSOD, and to highlight highly suggestive patterns of clinical, paraclinical or imaging presentations in order to improve differentiation. With overlay in clinical manifestations between MS and NMOSD, magnetic resonance imaging (MRI) of the brain, orbits and spinal cord, serology, and most importantly, high index of suspicion based on pattern recognition, will help lead to the final diagnosis. View Full-Text
Keywords: MS; NMOSD; clinically isolated syndrome (CIS); optic neuritis; transverse myelitis; brainstem syndrome; tumefactive demyelinating lesions; AQP4 antibodies; MOG antibodies MS; NMOSD; clinically isolated syndrome (CIS); optic neuritis; transverse myelitis; brainstem syndrome; tumefactive demyelinating lesions; AQP4 antibodies; MOG antibodies

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Supplementary material

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Zabad, R.K.; Stewart, R.; Healey, K.M. Pattern Recognition of the Multiple Sclerosis Syndrome. Brain Sci. 2017, 7, 138.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Brain Sci. EISSN 2076-3425 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top